midi compounded semaglutide + B12 - Weight Loss Compounded Weight Loss Medications
Description
The most frequent observation in FY25 was the failure of a quality control unit to ensure drug products manufactured are in compliance with current good manufacturing practices (cGMP), in accordance with 21 CFR 211.22
Potential Risks of Compounded Semaglutide Compounded semaglutide carries several risks that patients should know
Data from the in-trial period
(2024), 81:e41e43
However, clinicians should conduct a thorough baseline assessment before initiating semaglutide
Numerous patients have reported gastrointestinal issues after taking the drug, including gastroparesis or stomach paralysis
